FDG PET与CT影像组学特征鉴别原发性与转移性肺部病变的能力
回顾性纳入534例肺部病变患者,从半自动分割的PET和CT图像提取影像组学纹理特征,用线性判别分析在训练组和验证组中分类原发与转移性病变并区分原发肺癌亚型。PET数据集鉴别原发与转移的AUC在训练组和验证组分别为0.92±0.01和0.91±0.03,CT数据集分别为0.79±0.03和0.70±0.04。
要点
- PET影像组学特征可区分原发性与转移性肺部病变,验证组AUC为0.91±0.03。
- CT影像组学特征同样可区分原发与转移,验证组AUC为0.70±0.04。
- PET特征对原发肺癌亚型鉴别显示出潜力,验证组AUC最高达0.88±0.04。
核心结论
- PET影像组学特征能够区分原发性与转移性肺部病变,并显示出识别原发性肺癌亚型的潜力。
研究设计与样本
- 回顾性研究纳入534例肺部病变患者,从半自动分割的PET和CT图像中用LIFEx软件包提取影像组学纹理特征,全部患者均有组织学数据。
- 患者队列分为训练组和验证组,采用线性判别分析以直接法和后向逐步法分类病变,并通过100次不同训练/验证组分配重复整个过程检验稳健性。
- 评分指标包括受试者工作特征曲线下面积(AUC)、灵敏度、特异度和准确率。
主要发现
- CT数据集鉴别原发肿瘤与转移灶的AUC在训练组为0.79±0.03、验证组为0.70±0.04;PET数据集训练组为0.92±0.01、验证组为0.91±0.03。
- 线性判别分析直接法和后向消除策略识别的AUC截断阈值:CT数据集分别为-0.79±0.06和-0.81±0.08,PET数据集分别为-0.69±0.05和-0.68±0.04。
- 基于CT特征区分原发亚型,训练组和验证组AUC分别为:腺癌(Adc)vs.鳞状细胞癌(Sqc)或其他为0.81±0.02和0.69±0.04;Sqc vs. Adc或其他为0.85±0.02和0.70±0.05;其他 vs. Adc或Sqc为0.77±0.03和0.57±0.05。
- 基于PET数据的相同分析,训练组和验证组AUC分别为:0.90±0.10和0.80±0.04、0.80±0.02和0.61±0.06、0.97±0.01和0.88±0.04。
关键数值与推荐
- CT数据集鉴别原发与转移的AUC:训练组0.79±0.03,验证组0.70±0.04。
- PET数据集鉴别原发与转移的AUC:训练组0.92±0.01,验证组0.91±0.03。
- CT数据集直接法和后向消除策略的AUC截断阈值分别为-0.79±0.06和-0.81±0.08;PET数据集分别为-0.69±0.05和-0.68±0.04。
- CT特征区分Adc vs. Sqc或其他:训练组AUC 0.81±0.02,验证组0.69±0.04;Sqc vs. Adc或其他:训练组0.85±0.02,验证组0.70±0.05;其他 vs. Adc或Sqc:训练组0.77±0.03,验证组0.57±0.05。
- PET特征区分Adc vs. Sqc或其他:训练组AUC 0.90±0.10,验证组0.80±0.04;Sqc vs. Adc或其他:训练组0.80±0.02,验证组0.61±0.06;其他 vs. Adc或Sqc:训练组0.97±0.01,验证组0.88±0.04。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the ability of CT and PET radiomics features to classify lung lesions as primary or metastatic, and secondly to differentiate histological subtypes of primary lung cancers. METHODS: A cohort of 534 patients with lung lesions were retrospectively studied. Radiomics texture features were extracted using the LIFEx package from semiautomatically segmented PET and CT images. Histology data were recorded in all patients. The patient cohort was divided into a training and a validation group and linear discriminant analysis (LDA) was performed to classify the lesions using both direct and backward stepwise methods. The robustness of the procedure was tested by repeating the entire process 100 times with different assignments to the training and validation groups. Scoring metrics included analysis of the receiver operating characteristic curves in terms of area under the curve (AUC), sensitivity, specificity and accuracy. RESULTS: Radiomics features extracted from CT and PET datasets were able to differentiate primary tumours from metastases in both the training and the validation group (AUCs 0.79 ± 0.03 and 0.70 ± 0.04, respectively, from the CT dataset; AUCs 0.92 ± 0.01 and 0.91 ± 0.03, respectively, from the PET dataset). The AUC cut-off thresholds identified by LDA using direct and backward elimination strategies were -0.79 ± 0.06 and -0.81 ± 0.08, respectively (CT dataset) and -0.69 ± 0.05 and -0.68 ± 0.04, respectively (PET dataset). For differentiation between primary subgroups based on CT features, the AUCs in the training and validation groups were 0.81 ± 0.02 and 0.69 ± 0.04 for adenocarcinoma (Adc) vs. squamous cell carcinoma (Sqc) or "Other", 0.85 ± 0.02 and 0.70 ± 0.05 for Sqc vs. Adc or Other, and 0.77 ± 0.03 and 0.57 ± 0.05 for Other vs. Adc or Sqc. The same analyses for the PET data revealed AUCs of 0.90 ± 0.10 and 0.80 ± 0.04, 0.80 ± 0.02 and 0.61 ± 0.06, and 0.97 ± 0.01 and 0.88 ± 0.04, respectively. CONCLUSION: PET radiomics features were able to differentiate between primary and metastatic lung lesions and showed the potential to identify primary lung cancer subtypes.
引用
- Kirienko M, Cozzi L, Rossi A, et al. Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. Eur J Nucl Med Mol Imaging. 2018. PMID: 29623375. doi:10.1007/s00259-018-3987-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。